Market Signal Briefing

Fans of football and ‘Dancing With the Stars' are hooking up antennas to stay tuned in.

November 08, 2025 6:06 AM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in DexCom, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/dexcom-inc-class-action-lawsuit.

Investors have until December 26, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in DexCom securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Prime v. DexCom, Inc., et al., No. 1:25-cv-08912.

Why Was DexCom Sued Under the Federal Securities Laws?

DexCom manufactures continuous glucose monitoring ("CGM") systems, including the Dexcom G6 and its flagship Dexcom G7.

During the relevant period, DexCom touted the reliability and accuracy of the G7, claiming it was "the most accurate CGM" on the market. The company also told investors that enhancements it made to the G7 were "making it even better" and "enrich[ing] the experiences" of its customers.

As alleged, in truth, DexCom made unauthorized design changes to the G6 and G7, which reduced the accuracy of the devices and exposed customers to potentially life-threatening health risks, and the company ignored safety issues to keep costs down.

The Stock Declines as the Truth Is Revealed

Between March and October 2025, DexCom faced multiple setbacks tied to G6 and G7 quality issues, each triggering significant stock declines. On March 7, 2025, the company disclosed it received an FDA warning letter regarding manufacturing and quality control concerns, which caused DexCom stock to decline $7.12 per share, or more than 9%.

When the FDA published the letter on March 25, 2025, revealing DexCom had modified the G6 and G7 without approval, and that the modifications reduced the accuracy of the products and put customers' health at risk, DexCom stock fell another $3.19 per share, or more than 4%, over two trading days.

Then, on September 18, Hunterbrook published "Dexcom's Fatal Flaws," a report based on FDA documents, and the accounts of doctors, patients, and DexCom employees, which revealed "G7 users have been hospitalized and died" and that "Dexcom staff say corporate culture put margins over safety." The Hunterbrook report caused a nearly 12% drop of $8.99 per share over two trading days.

Click here for more information: https://www.bfalaw.com/cases/dexcom-inc-class-action-lawsuit.

What Can You Do?

If you invested in DexCom you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/dexcom-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/dexcom-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273539

November 08, 2025 6:07 AM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

Investors have until December 30, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Synopsys securities. The class action is pending in the U.S. District Court for the Northern District of California and is captioned Kim v. Synopsys, Inc., et al., No. 3:25-cv-09410.

Why Was Synopsys Sued for Securities Fraud?

Synopsys provides design automation software products used to design and test integrated circuits. The Company's Design IP segment, which provides pre-designed silicon components to semiconductor companies, has been the Company's fastest-growing segment, growing from 25% of its revenue in 2022, to 31% in 2024.

During the relevant period, Synopsys told investors that its customers "rely on Synopsys IP to minimize integration risk and speed time to market" and that it was seeing "strength in Europe and South Korea." Synopsys also stated it was "continuing to develop and deploy[] AI into our products and the operations of our business."

As alleged, in truth, the Company's Design IP customers began to require additional customization for IP components, which was deteriorating the economics of its Design IP business and jeopardizing its business model.

The Stock Declines as the Truth Is Revealed

On September 9, 2025, Synopsys released its Q3 2025 financial results, revealing its "IP business underperformed expectations." The Company reported revenue for its Design IP segment of $425.9 million, a 7.7% decline year-over-year and net income of $242.5 million, a 43% year-over-year decline. The Company revealed that its Design IP customers require "more and more customization," which "takes longer" and requires "more resources." As a result, the Company stated it was having "an ongoing dialogue with our customers" regarding changing its business model. This news caused the price of Synopsys stock to fall $217.59 per share, or nearly 36%, from $604.37 per share on September 9, 2025, to $387.78 per share on September 10, 2025.

Click here for more information: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

What Can You Do?

If you invested in Synopsys you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273547

November 08, 2025 6:08 AM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Stride, Inc. (NYSE: LRN) for potential violations of the federal securities laws.

If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

Why Is Stride Being Investigated for Securities Fraud?

Stride is an education technology company that provides an online platform to students throughout the U.S. During the relevant period, Stride stated it was seeing "record demand" for its products and services and that its customers and potential customers "continue to choose us in record numbers." Stride also told investors it was continuing to invest in its career platform and programs.

In truth, it appears Stride was in the midst of severely unpopular platform changes that resulted in admittedly poor customer experiences and that drove students away from the platform.

Why Did Stride's Stock Drop?

On October 28, 2025, Stride revealed that its growth rate fell short of expectations because of poorly executed upgrades to its learning and technology platforms. The Company stated that the upgrades created a "poor customer experience" that resulted in "higher withdrawal rates," "lower conversion rates," and drove students away. Stride estimated the impact caused approximately 10,000-15,000 fewer enrollments and stated that, because of this, its outlook is "muted" compared to prior years.

This news caused the price of Stride stock to drop $83.48 per share, or more than 54%, from a closing price of $153.53 per share on October 28, 2025, to $70.05 per share on October 29, 2025.

Click here for more information: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

What Can You Do?

If you invested in Stride you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273545

November 08, 2025 6:09 AM EST | Source: Bleichmar Fonti & Auld
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jamf Holding Corp.'s (NASDAQ: JAMF) board of directors for potential breaches of their fiduciary duties to shareholders in connection with a potential take-private sale of Jamf that would cash out every stockholder for $13.05 per share.

If you are a current shareholder of Jamf, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jamf-holding-corp-take-private-investigation.

Why is Jamf being Investigated?

On October 29, 2025, Jamf announced that it had agreed to be acquired by Francisco Partners Management, L.P. ("FP") for $13.05 per share. This price may represent an unfairly low price being paid to Jamf stockholders and may be the result of conflicts of interest between the Jamf board of directors, FP, and Vista Equity Partners ("Vista").

Vista exercises significant power over Jamf, owning 34.4% of the outstanding stock, and having contractual rights to appoint four out of the nine members of the Jamf board of directors. The board of directors of Jamf did not employ an independent special committee to evaluate the transaction. While the deal is conditioned on a stockholder vote, the Company has not excluded Vista from that vote.

BFA Law is investigating Jamf's board of directors and Vista to ascertain whether they have breached fiduciary duties to Jamf stockholders in connection with the contemplated transaction.

Click here for more information: https://www.bfalaw.com/cases/jamf-holding-corp-take-private-investigation.

What Can You Do?

If you are a current holder of Jamf you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/jamf-holding-corp-take-private-investigation

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/jamf-holding-corp-take-private-investigation

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273541

Nvidia and Palantir are two of the biggest names in AI investing.

Palantir (PLTR +1.66%) and Nvidia (NVDA +0.04%) are two of the biggest names in artificial intelligence (AI). Neither company is competing with the other, as Palantir is a software play while Nvidia provides accelerated computing hardware to run AI workloads. The two recently announced a partnership, and this is massive news for both companies.

For Nvidia, it integrated Palantir Ontology into its graphics processing units (GPUs). This integrated technology stack will be far more efficient and unlock new capabilities for Palantir's customers who deploy Nvidia's GPUs.

Time will tell how this impacts both businesses, but I'm only interested in buying one stock in this partnership.

Which one has my eye? Let's find out.

Image source: Getty Images.

Palantir's business will be more sustainable over the long run
Palantir is a software business, and each year its customers must pay the subscription fee to continue running its AI-powered data analytics software. With Palantir's software becoming increasingly more integrated into its clients' operations, this makes the software more and more sticky each year. As a result, Palantir is likely locking in customers for the foreseeable future.

Today's Change

(

1.66

%) $

2.90

Current Price

$

177.95

Nvidia's computing business is a bit different. For Nvidia to continue growing, it must continue selling new GPUs each year. Right now, this isn't a problem, as it's releasing a new iteration about every year with performance that makes the previous years' model look obsolete.

Eventually, we'll reach a performance barrier and have the necessary AI computing capacity built out to operate as an AI-integrated society. When that happens, Nvidia's sales will fall as it will only be funding incremental computing capacity buildout and replacing outdated and burnt-out computing units.

Today's Change

(

0.04

%) $

0.07

Current Price

$

188.15

This makes Palantir's business far more sustainable over the long run, and I'd rather own it than Nvidia. However, there's one factor that makes me wary of Palantir's future, and it all comes down to stock valuation.

Nvidia's stock price is far more reasonable
While picking a successful company is one thing, ensuring that you pay the right price for it is another. Even the best company bought at the wrong price can turn into a disastrous investment, and that's exactly where I see Palantir's stock right now.

PLTR PE Ratio (Forward 1y) data by YCharts

Despite similar growth rates, Palantir is valued at a far higher premium than Nvidia. With Nvidia trading at about 30 times next year's earnings, it's far more reasonable than Palantir, which is trading at 224 times 2026's earnings.

While I'm OK giving Palantir some premium due to its stickier customer base and rapidly expanding product line, the premium investors must pay to own the stock today is far too great.

For Palantir to return to a reasonable valuation level, let's say 50 times trailing earnings, it would need to sustain incredible growth for a long time. If it can continue growing revenue at a compounded annual growth rate (CAGR) of about 50% (an incredible feat) over the next five years, that would give it annual revenue of $26 billion. At a profit margin of 35% with a 50 times earnings valuation, that would value the stock at $457 billion. Considering Palantir's market cap today is about $450 billion, that doesn't leave room for a lot of growth over the next five years.

Meanwhile, Nvidia is slated to post monster revenue growth as well, with global data center capital expenditures expected to rise from $600 billion in 2025 to $3 trillion to $4 trillion. So, while Palantir is still trying to grow into its premium price tag, Nvidia will be able to convert all of its growing business directly into stock price performance. This makes Nvidia the better stock pick over the next five years, even if Palantir's business continues to excel (and I think it will).

Analyst’s Disclosure:I/we have a beneficial long position in the shares of AMZN, SHOP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Q3: 2025-11-07 Earnings SummaryEPS of $1.21 beats by $0.14

 |

Revenue of

$629.10M

(40.35% Y/Y)

beats by $34.90M

Lundin Gold Inc. (LUG:CA) Q3 2025 Earnings Call November 7, 2025 11:00 AM EST

Company Participants

Ronald Hochstein - President, CEO & Director
James Beck - President, CEO & Director
Terrence F. Smith - Chief Operating Officer
Chester See - Chief Financial Officer

Conference Call Participants

Fahad Tariq - Jefferies LLC, Research Division
Don DeMarco - National Bank Financial, Inc., Research Division

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to Lundin Gold's Q3 2025 Financial Results Call. [Operator Instructions] This call is being recorded on Friday, November 7, 2025. I would now like to turn the conference over to Ron Hochstein. Please go ahead.

Ronald Hochstein
President, CEO & Director

Thank you, Natasha, and good morning, everyone. Thank you all for joining us today. I'm joined by Jamie Beck, Lundin Gold's new President and CEO; Terry Smith, Chief Operating Officer; and Chester See, our Chief Financial Officer. We're going to take you through our results for the third quarter of 2025.

Please note Lundin Gold's disclaimers on this slide. This discussion includes forward-looking information. Actual future results may differ from expected results for a variety of reasons described in the caution regarding forward-looking information and statements section of our press release. Lundin Gold is a U.S. dollar reporting entity, and all amounts in this presentation refer to U.S. dollars, unless otherwise indicated. As many of you know, I've resigned as President and CEO of Lundin Gold yesterday to pursue another opportunity within the Lundin Gold. It is my honor to participate in this conference call and discuss Lundin Gold's third quarter results.

It is also my privilege to formally introduce you to Jamie Beck. Jamie, a long-standing member of the Lundin Gold of Companies, and most recently, CEO of Filo is as of today, the new President and CEO of Lundin Gold. I have worked with

Recommended For You

Kenneth L. Cornick, a member of the Board of Directors for Clarivate Plc (CLVT +0.88%), reported a purchase of 725,000 shares in the company in multiple open-market transactions valued at approximately $2.5 million, according to a SEC Form 4 filing.

This resulted in 1,032,711 direct and indirect share ownership, post-transaction.

Transaction summaryMetricValueContextShares traded725,000Total shares purchased in open-market transactionsTransaction value~$2.5 millionBased on SEC Form 4 weighted average purchase price ($3.42)Post-transaction shares1,032,711Direct and indirect ownership after transactionPost-transaction value (direct ownership)~$3.7 millionDirect and indirect holdings valued at market close November 3, 2025Transaction value based on SEC Form 4 weighted average purchase price ($3.42).

Key questionsWhat distinguishes this transaction in terms of timing and market context?
The purchase occurred between October 31 and November 3, 2025, at a weighted average price of around $3.42 per share, during a period when Clarivate shares had declined ~26% over the prior year as of November 3, 2025. This marks a sizable allocation in the context of an extended negative return environment for the stock.How did this transaction affect Kenneth Cornick’s direct holdings?
Following the purchase, direct ownership stood at 32,711 shares, indicating that all acquired shares were not retained under direct ownership.Were there any indirect holdings or entities involved?
Yes,  indirect ownership totaled one million shares after the purchase as reported in this Form 4 transaction.How does the transaction value compare to Clarivate’s recent market valuation?
The transaction represented a purchase worth approximately $2.5 million, with Clarivate’s market capitalization at $2.28 billion as of November 3, 2025, making the trade immaterial at the company scale, but significant at the insider level.Company overviewMetricValuePrice (as of market close November 3, 2025)$3.54Market capitalization$2.28 billionRevenue (TTM)$2.50 billion1-year price change(26.28%)Note: 1-year performance is calculated using November 3, 2025 as the reference date.

Company snapshotClarivate provides information services and analytics, including research intelligence (Web of Science, InCites), life sciences data (Cortellis, Newport Integrity), intellectual property solutions (Derwent, CompuMark), and brand protection (MarkMonitor).The company generates revenue through subscription-based data platforms, analytics tools, and professional services supporting research, intellectual property, and brand management.Clarivate serves government and academic institutions, life sciences companies, and research-driven corporations globally.Clarivate PLC is a global provider of structured data and analytics solutions, enabling organizations to discover, protect, and commercialize innovations. With a diverse portfolio of proprietary platforms and services, Clarivate supports decision-making across research, intellectual property, and brand management. The company leverages its scale and specialized datasets to deliver critical insights to a broad base of institutional clients worldwide.

Foolish takeClarivate Board member Kenneth L. Cornick's purchase of the company's stock comes after Clarivate reported third quarter earnings results on Oct. 29. The buy comes despite shares being down from the 52-week high of $5.88 reached last December, suggesting he has a bullish outlook towards Clarivate.

The company's stock is down due to several factors. One of these is Clarivate's soft sales in 2025. Although Q3 revenue of $623.1 million was slightly ahead of 2024's $622.2 million, through three quarters, sales were down 3% year over year to $1.9 billion.

In addition, Clarivate's debt totaled a significant $4.5 billion at the end of Q3 compared to cash and equivalents of $318.7 million. The company isn't profitable with a Q3 net loss of $28.3 million, although that's an improvement over the prior year's loss of $65.6 million.

While Mr. Cornick's purchase signals confidence in the company's future, Clarivate's tepid performance and large debt suggest the prudent approach is to wait to see how its business fares over the coming quarters before deciding to invest.

GlossaryInsider transaction: A trade of company securities by an executive, director, or large shareholder, reported to regulators.

Open-market transaction: The purchase or sale of securities on a public exchange, not through private negotiation.

Direct ownership: Shares held personally by an individual, not through trusts or other entities.

Indirect holdings: Shares owned through another entity, such as a trust or partnership, rather than held personally.

Form 4: A required SEC filing disclosing insider trades in a company's securities.

Weighted average purchase price: The average price paid per share, accounting for different prices across multiple trades.

Immaterial: Too small to significantly impact a company's financial position or market value.

Subscription-based data platforms: Services providing ongoing access to data or analytics for a recurring fee.

Proprietary platforms: Technology or services owned and controlled by a company, not available for public use.

TTM: The 12-month period ending with the most recent quarterly report.

Exchange Income Corporation ( EIF:CA ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Michael Pyle - CEO & Director Richard Wowryk - Chief Financial Officer Jake Trainor - President Travis Muhr - Chief Administrative Officer Conference Call Participants Steven Hansen - Raymond James Ltd., Research Division Cameron Doerksen - National Bank Financial, Inc., Research Division James McGarragle - RBC Capital Markets, Research Division Matthew Lee - Canaccord Genuity Corp., Research Division Krista Friesen - CIBC Capital Markets, Research Division Tim James - TD Cowen, Research Division Jeff Fenwick - Cormark Securities Inc., Research Division Konark Gupta - Scotiabank Global Banking and Markets, Research Division Amr Ezzat - Ventum Financial Corp., Research Division Chris Murray - ATB Capital Markets Inc., Research Division Gary Ho - Desjardins Securities Inc., Research Division Razi Hasan - Paradigm Capital Inc., Research Division Michael Goldie - BMO Capital Markets Equity Research Presentation Operator Good morning, everyone.

SummaryeHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships.EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins.Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround.We rate EHTH a BUY, expecting a rebound to tangible book value ($14-$18/share) if FY25 guidance is met or exceeded. Sundry Photography/iStock Editorial via Getty Images

eHealth Inc (EHTH) is an online health insurance marketplace offering access to over 180 insurers. For over two decades, eHealth has been an industry leader in digital access for individuals and businesses to purchase health

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Nvidia's biggest business can keep growing at a terrific pace over the next couple of years.

The data center business has been the cornerstone of Nvidia's (NVDA +0.04%) outstanding surge in the past three years. This business accounts for the majority of Nvidia's top line, and that can be attributed to its dominant presence in the market for artificial intelligence (AI) chips.

According to one estimate, Nvidia commands a whopping 90% share of the AI chip market. This explains why the company's data center revenue is substantially higher than the competition.

Image source: The Motley Fool.

The good part is that Nvidia's data center business could soar to new heights in the next couple of years. Let's see why that's likely to be the case.

Nvidia CEO Jensen Huang suggests there is a huge backlog for its AI chips
Nvidia's data center business has generated just over $80 billion in revenue in the first half of the ongoing fiscal year 2026, accounting for 88% of its top line. The company is expecting $54 billion in revenue in Q3. Assuming the data center segment's share remains in line with what we have seen in the first half of the year, this business is likely to account for $47.5 billion in fiscal Q3 revenue.

Today's Change

(

0.04

%) $

0.07

Current Price

$

188.15

The quarterly revenue run rate based on Nvidia's data center revenue for the first nine months of the year suggests that it could end fiscal 2026 (which ends in January 2026) with $170 billion in data center revenue. CEO Jensen Huang pointed out at a recent developer conference in Washington, D.C., that the company has secured over $500 billion worth of orders for its current generation of Blackwell processors and the upcoming Rubin graphics processing units (GPUs), which will be launched next year.

Now, Huang didn't point out if all of these orders are pending, or if they include the revenue that Nvidia has already generated from the sale of its current generation Blackwell processors. But even if we assume that the $500 billion figure is inclusive of the Blackwell orders already fulfilled, Nvidia will still have a sizable backlog.

Nvidia's Blackwell GPUs went on sale in the fourth quarter of calendar 2024, which coincided with two months of its fiscal 2025 fourth quarter. Nvidia sold $11 billion worth of Blackwell processors in that quarter. Assuming the entire $170 billion data center revenue that Nvidia is projected to generate in fiscal 2026 is from sales of its Blackwell GPUs, it has sold around $180 billion worth of these processors since they were launched.

That still leaves the company with a potential $320 billion in backlog for fiscal 2027 (which will begin in January next year). If Nvidia manages to convert all of that backlog into revenue during the fiscal year, its data center revenue could jump by an estimated 88% next year (from fiscal 2026's estimated sales of $170 billion).

You may be wondering if Nvidia can indeed convert the entirety of its projected backlog into revenue next year. The good part is that the company's foundry partner, Taiwan Semiconductor Manufacturing Company, is expected to increase its advanced chip packaging capacity by 33% next year. With Nvidia reportedly securing 60% of that capacity for itself, there is a good chance that it could indeed turn that massive order backlog into revenue.

Hefty data center spending will be a tailwind in 2027
Nvidia estimates that data center capital spending is likely to grow at an annual pace of 40% between 2025 and 2030, with annual spending estimated to land between $3 trillion and $4 trillion by the end of the decade. The company estimates that data center capital expenditures (capex) could land at $1 trillion next year before approaching $1.5 trillion in 2027.

So, there is ample incremental revenue opportunity for Nvidia to sustain its data center growth beyond next year. Even if we assume that the company's data center revenue grows in line with the estimated annual growth of 40% in data center capex, its revenue from this segment could jump to almost $450 billion in 2027 (which coincides with Nvidia's fiscal 2028).

That points toward a potential increase of 165% from the $170 billion data center revenue that Nvidia may deliver this year. Analysts, meanwhile, are expecting Nvidia to generate $345 billion in revenue after a couple of fiscal years, having raised their estimate notably of late.

NVDA Revenue Estimates for 2 Fiscal Years Ahead data by YCharts

Nvidia, therefore, has the potential to easily grow at a much stronger pace than what analysts are expecting thanks to its AI chip dominance, tremendous backlog, and further growth in AI chip spending. That could ensure more upside for this high-flying AI stock over the next three years.

Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Intel, International Business Machines, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends the following options: short November 2025 $21 puts on Intel. The Motley Fool has a disclosure policy.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummaryPCM Fund is evaluated as an investment, focusing on its strategy of high current income via non-agency mortgage and high-yield corporate debt.Despite a generally risk-on market, PCM has delivered only modest returns, validating a cautious stance.I view the premium to NAV, weak income metrics, and outpacing of downgrades (over upgrades) in the high yield credit market as all reasons to stay on the sidelines. RerF/iStock via Getty Images

Main Thesis & Background The purpose of this article is to evaluate the PCM Fund (PCM) as an investment option at its current market price. This is a closed-end fund whose investment objective

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Q3: 2025-11-06 Earnings SummaryEPS of -$0.25 misses by $0.18

 |

Revenue of

$0.00

beats by $0.00

USA Rare Earth, Inc. (USAR) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST

Company Participants

Lionel McBee - Vice President of Investor Relations
Barbara Humpton - CEO & Director
William Steele - Chief Financial Officer

Conference Call Participants

Neal Dingmann - William Blair & Company L.L.C., Research Division
George Gianarikas - Canaccord Genuity Corp., Research Division
Derek Soderberg - Cantor Fitzgerald & Co., Research Division
Subhasish Chandra - The Benchmark Company, LLC, Research Division
Sujeeva De Silva - ROTH Capital Partners, LLC, Research Division

Presentation

Operator

Good afternoon, and welcome to USA Rare Earth's 2025 Third Quarter Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Lionel McBee, Vice President of Investor Relations. Please go ahead.

Lionel McBee
Vice President of Investor Relations

Thank you, operator. Hello, everyone, and welcome to USA Rare Earth's 2025 Third Quarter Earnings Conference Call. I'm joined today with our Chief Executive Officer, Barbara Humpton; and our Chief Financial Officer, Rob Steele.

Earlier this afternoon, we issued our third quarter fiscal 2025 results. Our 10-Q, earnings release and slide presentation can be found on the Investor Relations section of our website at usare.com. Following Barbara and Rob's discussion of our quarterly results and updates on the business, we will open the lines for Q&A.

During today's call, we may make projections and other forward-looking statements under the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995 regarding future events or the future financial performance of the company. These statements may discuss our business, economic and market outlook, growth expectations, new products and their performance, cost structure and business strategy. Forward-looking statements are based on information currently available to us and on management's beliefs, assumptions, estimates or projections. Forward-looking statements are not guarantees of future performance and are subject to certain

Recommended For You

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Strong sales growth isn't enough to offset the impact of tariffs on the beauty company's profits.

Shares of e.l.f. Beauty (ELF 3.66%) were slammed after the company's latest quarterly update, losing more than a third of their value. The pullback was driven by management's disappointing full-year outlook -- especially as it relates to its profit guidance.

The beauty company, known for value-priced cosmetics and a growing skin-care lineup, also closed its first quarter integrating Rhode -- Hailey Bieber's brand -- into its portfolio, which added a new growth lever but didn't quiet investor concerns about near-term profitability.

With the stock down about 40% year to date, it's a good time to take a look at the stock.

Image source: Getty Images.

Still a growth story
Despite the stock's ugly performance recently, e.l.f. is still a growth story. Net sales for its fiscal second quarter (the three-month period ended Sept. 30) increased 14% to $343.9 million, marking the company's 27th straight quarter of growth.

Additionally, management highlighted market share gains for the core e.l.f. brand during the quarter and called out a "record-breaking launch of Rhode in Sephora North America."

But profits were challenged as operating expenses also moved higher and gross margin contracted. Adjusted sales, general, and administrative expenses (SG&A) rose to 56% of sales as the company leaned into spending aimed at boosting brand awareness. In addition, e.l.f.'s gross margin dipped by about 165 basis points to 69%, with the company citing higher tariff costs as the main headwind. All of this led to adjusted diluted earnings per share landing at $0.68, down from $0.77 in the year-ago period.

A tariff problem
Where things really get murky is guidance.

First of all, management said it expects full-year fiscal 2026 net sales between $1.55 billion and $1.57 billion. While this translates to about 18% to 19% growth versus last year, the guidance range was below analysts' consensus forecast for the key metric. Even worse was a forecast for fiscal 2026 adjusted earnings per share of $2.80 to $2.85 -- significantly below last year's $3.39. On a similar note, adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) are projected at $302 million to $306 million, only slightly above fiscal 2025's $297 million.

With about 75% of its global production sourced in China, tariffs are the primary culprit for e.l.f.'s disappointing profit outlook.

Today's Change

(

-3.66

%) $

-2.80

Current Price

$

73.74

So, is the stock attractive after its big drawdown? Unfortunately, I don't think so. Shares currently trade at a price-to-earnings ratio in the mid-forties -- and tariffs may weigh on earnings going forward. In addition, the script has flipped; the company's China-dependent supply chain has gone from an advantage to a disadvantage.

Sure, e.l.f.'s growth is impressive. But the company's shares still command a premium valuation multiple on par with growth stocks boasting durable competitive advantages. And these latest results show that e.l.f.'s competitive advantage may not be as durable as investors thought. If the company can't keep its production costs in check, it could lose its edge as the low-cost leader in the space. Further, even if tariffs are revoked at some point, there's always the risk that another tariff war will ensue in the future.

Ultimately, the impact of tariffs on e.l.f.'s business has exposed a weakness that investors may not be able to unsee. To address the situation, e.l.f. will need to diversify its supply chain -- and that could negatively impact its value proposition with customers.

For now, I'd avoid e.l.f. shares. Despite the big decline in the stock price, shares look overvalued given the company's heavy dependence on China production. If the sell-off worsens, I might reconsider my stance. For now, however, I don't believe the stock price fully bakes in the challenges the company is facing.

SummaryVornado Realty Trust is a leading REIT with a diverse portfolio of office, retail, marketplace, and residential properties in New York.VNO's preferred shares, especially VNO.PR.O, offer yields above 7% and present a compelling risk-return profile compared to peers and OTC bonds.Credit ratings for VNO and its preferreds are non-investment grade but remain competitive within the sector, supported by strong asset coverage and stable cash flows.VNO.PR.O is recommended for income-focused investors, offering reliable distributions and potential price upside, despite lower credit ratings.oatawa/iStock via Getty Images

Today's article is about one of the oldest REIT companies and one of the largest owners of commercial and office properties in New York. The following lines are about Vornado Realty Trust (VNO) and its

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Rightmove plc (OTCPK:RTMVY) Shareholder/Analyst Call November 7, 2025 4:30 AM EST Company Participants Johan Svanstrom - CEO & Executive Director Tarah Lourens - Chief Operating Officer Ruaridh Hook - CFO & Executive Director Conference Call Participants Jessica Pok - Peel Hunt LLP, Research Division William Packer - BNP Paribas, Research Division Marcus Diebel - JPMorgan Chase & Co, Research Division Giles Thorne - Jefferies LLC, Research Division Joseph Barnet-Lamb - UBS Investment Bank, Research Division Andrew Ross - Barclays Bank PLC, Research Division Ciaran Donnelly - Citigroup Inc., Research Division Annick Maas - Sanford C. Bernstein & Co., LLC.

James Ding
Nov 08, 2025 07:36

ATOM price prediction shows potential 50% upside to $4.50 in next 4-6 weeks as MACD turns bullish and price holds critical $2.35 support level.

Cosmos (ATOM) is showing early signs of a technical reversal after touching its 52-week low at $2.51. With the current price at $2.99 and bullish momentum building through MACD indicators, this ATOM price prediction explores the potential for a significant recovery rally in the coming weeks.

ATOM Price Prediction Summary
• ATOM short-term target (1 week): $3.40 (+13.7%)
• Cosmos medium-term forecast (1 month): $4.20-$4.70 range (+40-57%)
• Key level to break for bullish continuation: $3.37 immediate resistance
• Critical support if bearish: $2.35 must hold for uptrend validation

Recent Cosmos Price Predictions from Analysts
The latest analyst predictions present a mixed but increasingly optimistic outlook for ATOM. Changelly's conservative $3.00 ATOM price target reflects the current bearish sentiment, while CoinCodex's progressive forecasts show growing confidence with targets ranging from $4.36 in the short term to $5.29 for longer-term horizons.

The most significant factor in these Cosmos forecast models is the neutral Fear & Greed Index at 52, suggesting the extreme bearish sentiment may be exhausting. CoinCodex's analysis highlighting the convergence of 50-day and 200-day SMAs around $4.50 creates a critical technical inflection point that could determine ATOM's next major directional move.

ATOM Technical Analysis: Setting Up for Reversal
The current Cosmos technical analysis reveals several bullish divergences forming at critical support levels. ATOM's RSI at 46.01 sits in neutral territory, providing room for upward momentum without entering overbought conditions. More importantly, the MACD histogram at 0.0301 shows the first signs of bullish momentum after an extended bearish period.

ATOM's position within the Bollinger Bands at 0.4866 suggests the token is approaching oversold territory, historically a favorable entry zone for medium-term positioning. The daily ATR of $0.27 indicates moderate volatility, which could support sustained directional moves once momentum builds.

Volume analysis from Binance shows $18.9 million in 24-hour trading activity, representing solid liquidity for the recent 8.92% daily gain. This volume surge coinciding with price recovery suggests accumulation activity near the 52-week low support zone.

Cosmos Price Targets: Bull and Bear Scenarios
Bullish Case for ATOM
The primary bullish scenario for this ATOM price prediction centers on breaking above $3.37 immediate resistance. Success here opens the path toward the $4.20-$4.70 range where the 50-day and 200-day moving averages converge.

A break above $3.46 (upper Bollinger Band) would trigger momentum-based buying, likely pushing ATOM toward the $4.51 strong resistance level identified in recent analyst forecasts. The ultimate bullish ATOM price target sits at $5.29, representing a 77% gain from current levels and aligning with CoinCodex's long-term Cosmos forecast.

Bearish Risk for Cosmos
The bearish scenario activates if ATOM fails to hold the critical $2.35 support level. A break below this zone would invalidate the current reversal thesis and potentially send ATOM toward the $2.00 psychological support level.

The most significant risk factor remains the overall crypto market sentiment and Bitcoin's correlation effects. With 87% of market participants reportedly bearish according to recent sentiment analysis, any broader market weakness could pressure ATOM regardless of individual technical strength.

Should You Buy ATOM Now? Entry Strategy
Based on this Cosmos technical analysis, the current $2.99 price level presents a compelling risk-adjusted entry opportunity. The recommended strategy involves scaling into positions between $2.90-$3.10, with initial stops placed below the $2.35 critical support.

For aggressive traders, buying ATOM on any pullback toward $2.80 offers optimal risk-reward positioning. Conservative investors should wait for a confirmed break above $3.37 before establishing larger positions, accepting higher entry prices for reduced downside risk.

Position sizing should account for ATOM's current volatility, with recommended allocation not exceeding 2-3% of total portfolio value given the prediction's medium confidence level.

ATOM Price Prediction Conclusion
This comprehensive ATOM price prediction suggests a 40-57% upside potential over the next 4-6 weeks, with primary targets in the $4.20-$4.70 range. The prediction carries medium-to-high confidence based on bullish MACD divergence, oversold positioning, and strong support holding.

Key validation signals include sustained trading above $3.00, increasing volume on upward moves, and RSI progression above 50. Invalidation occurs on any daily close below $2.35, which would require reassessing the bullish Cosmos forecast thesis.

The timeline for this prediction spans 4-6 weeks for medium-term targets, with short-term validation expected within 7-10 days if momentum continues building. Traders should monitor the $3.37 resistance breakout as the critical catalyst for accelerating this ATOM price prediction scenario.

Image source: Shutterstock

atom price analysis
atom price prediction

Timothy Morano
Nov 08, 2025 07:42

LTC price prediction targets $106-$120 range within 2-4 weeks as Litecoin breaks above key resistance. Current bullish momentum suggests 20% upside potential.

Litecoin is displaying compelling technical signals that suggest a significant price breakout is imminent. With LTC currently trading at $100.04 after a remarkable 10.82% daily surge, multiple indicators are aligning to support a bullish LTC price prediction for the coming weeks.

LTC Price Prediction Summary
• LTC short-term target (1 week): $106-$109 (+6-9% from current levels)
• Litecoin medium-term forecast (1 month): $115-$125 range (+15-25% upside potential)
• Key level to break for bullish continuation: $106.98 resistance
• Critical support if bearish: $94-$96 (SMA 20 confluence zone)

Recent Litecoin Price Predictions from Analysts
The latest analyst forecasts show remarkable convergence around key resistance levels. Blockchain.News maintains an optimistic Litecoin forecast with targets ranging from $98.84 in the short term to $109.44 over the medium term. Their analysis specifically highlights the critical $106.98 resistance level as the gateway to higher prices.

More aggressive predictions come from AInvest, which identifies Litecoin's current position as testing a seven-year triangle resistance near $112. Their LTC price prediction suggests a breakout could drive prices to $120-$125, representing a 20-25% gain from current levels. Meanwhile, Gate.com's long-term outlook remains exceptionally bullish, projecting LTC could reach $201 by late 2025.

The consensus among analysts points to $106-$109 as the immediate LTC price target, with broader agreement that breaking the $106.98 resistance would unlock significantly higher targets.

LTC Technical Analysis: Setting Up for Bullish Breakout
The current Litecoin technical analysis reveals a compelling setup for upward momentum. LTC's position within the Bollinger Bands at 0.76 indicates the price is approaching the upper band at $104.72, suggesting strong buying pressure. However, the real catalyst lies just above current levels.

The RSI reading of 52.92 provides an ideal setup - it's in neutral territory with ample room to move higher without reaching overbought conditions. This contrasts favorably with many altcoins currently showing extended RSI readings. The MACD histogram's positive reading of 0.8561 confirms that bullish momentum is building, despite the MACD line itself remaining slightly negative.

Volume analysis supports the bullish thesis, with 24-hour Binance spot volume reaching $186.4 million during yesterday's 10.82% surge. This represents significant institutional and retail interest at these levels. The fact that LTC managed to break above both the 50-day SMA ($102.01) and 200-day SMA ($101.25) on substantial volume suggests this isn't a false breakout.

Litecoin Price Targets: Bull and Bear Scenarios
Bullish Case for LTC
The primary bullish LTC price prediction centers on breaking the immediate resistance at $106.98. Once cleared, this level should provide support for a move toward the $115-$120 range. The technical reasoning is straightforward: LTC has been consolidating in a multi-month pattern, and the recent volume surge suggests accumulation is complete.

The seven-year triangle pattern identified by AInvest adds significant weight to the bullish case. Triangle breakouts often produce moves equal to the height of the pattern, which in this case could justify targets as high as $125-$130. The 52-week high of $130.91 represents the ultimate bullish LTC price target for this cycle.

For the bullish scenario to unfold, LTC needs to maintain support above the $100 psychological level and demonstrate follow-through buying above $106.98. The ideal scenario would see LTC close above $109 on strong volume, confirming the breakout.

Bearish Risk for Litecoin
The primary risk to the bullish Litecoin forecast lies in a failure to break the $106.98 resistance convincingly. If LTC faces rejection at this level, the immediate support zones become critical. The SMA 20 at $95.05 represents the first significant support, followed by the lower Bollinger Band at $85.37.

A breakdown below $94 would invalidate the current bullish setup and could trigger a retest of the $87-$90 range. The bearish case would be confirmed by RSI falling below 45 and MACD histogram turning negative. In an extreme scenario, failure to hold the $85 support could lead to a test of stronger support at $79.68.

Should You Buy LTC Now? Entry Strategy
Based on the current Litecoin technical analysis, the optimal entry strategy involves a tiered approach. For aggressive traders, the current level around $100 offers an attractive entry point with a tight stop-loss below $96. This provides a favorable 3:1 risk-reward ratio targeting the initial resistance at $106-$109.

Conservative investors should wait for a confirmed breakout above $106.98 before establishing positions. This reduces risk but also limits upside potential. A breakout entry at $108-$109 with targets of $120-$125 still offers compelling returns with reduced downside risk.

Position sizing should reflect the volatility indicated by the ATR of $8.00. This suggests daily moves of $8 in either direction are normal, so position sizes should be calibrated accordingly. Stop-loss levels should be placed below the $94 support zone to allow for normal market fluctuations while protecting against significant losses.

LTC Price Prediction Conclusion
The convergence of technical indicators, analyst forecasts, and market structure strongly supports a bullish LTC price prediction for the next 2-4 weeks. The immediate target of $106-$109 carries high confidence, while the medium-term Litecoin forecast of $115-$125 depends on successful breakout confirmation.

Key indicators to monitor include RSI maintaining above 50, MACD histogram remaining positive, and most importantly, price action around the critical $106.98 resistance level. A decisive break above this level on strong volume would validate the bullish thesis and likely trigger the next leg higher.

The timeline for this LTC price prediction to unfold is relatively short - within 2-4 weeks based on current momentum. Failure to break resistance within this timeframe or a breakdown below $94 support would require reassessment of the bullish outlook. Overall confidence in the upside scenario is medium to high, supported by both technical analysis and analyst consensus around similar price targets.

Image source: Shutterstock

ltc price analysis
ltc price prediction

XRP price climbs past $2.30 as 21Shares' ETF amendment starts 20-day SEC countdown

Jessie A Ellis
Nov 08, 2025 07:55

XLM price prediction suggests a bounce to $0.34 resistance after finding support at $0.27. Technical analysis reveals neutral RSI and oversold conditions favoring short-term recovery.

XLM Price Prediction Summary
• XLM short-term target (1 week): $0.32 (+10.3% from current $0.29)
• Stellar medium-term forecast (1 month): $0.27-$0.36 trading range
• Key level to break for bullish continuation: $0.34 (immediate resistance)
• Critical support if bearish: $0.25 (immediate support level)

Recent Stellar Price Predictions from Analysts
The latest XLM price prediction landscape shows a divided market sentiment among leading analysts. Brave New Coin maintains a measured outlook with their $0.27 price target, identifying Stellar's current position near historically reactive demand zones. This aligns closely with CoinDesk's bearish assessment following XLM's breach below the critical $0.2800 support level, which triggered a massive 483% volume surge.

However, the Stellar forecast from COINOTAG NEWS presents a compelling contrarian view, highlighting the 700% growth in smart contracts and $5.4 billion in real-world asset volume as fundamental catalysts that could override short-term technical weakness. CoinLore's AI-driven models suggest a modest recovery to $0.2898, while Superex warns of November's historically challenging performance for XLM with a median -5.67% return.

The consensus among analysts points to near-term consolidation around the $0.27 support zone, with potential for recovery once technical conditions stabilize.

XLM Technical Analysis: Setting Up for Recovery
Current Stellar technical analysis reveals a cryptocurrency positioned for potential reversal after recent selling pressure. The RSI reading of 41.36 indicates neutral territory with room for upward movement before reaching overbought conditions. This XLM price target of $0.32 becomes achievable as the RSI has space to climb toward the 50-60 range.

The MACD histogram at -0.0003 shows bearish momentum is weakening, suggesting the selling pressure that drove XLM below $0.28 may be exhausting. With the current price of $0.29 sitting just above the lower Bollinger Band at $0.27, Stellar appears to be testing crucial support levels that have historically provided bounce opportunities.

Volume analysis supports this recovery thesis, as the recent 483% surge indicates capitulation selling may have cleared weak hands from the market. The 24-hour trading volume of $28.6 million on Binance suggests continued interest despite the technical challenges.

The key technical setup shows XLM trading below all major moving averages (SMA 20 at $0.30, SMA 50 at $0.34), but the proximity to these levels means a modest 3-17% rally could quickly restore bullish structure.

Stellar Price Targets: Bull and Bear Scenarios
Bullish Case for XLM
The primary XLM price target in a bullish scenario targets $0.34, representing the convergence of the SMA 50 and immediate resistance level. This represents a 17% upside from current levels and would confirm technical recovery.

A break above $0.34 opens the door to $0.41 strong resistance, where XLM faced rejection earlier in 2025. This extended target implies 41% upside potential if fundamental catalysts like the smart contract growth and RWA adoption drive sustained demand.

The bullish case requires XLM to reclaim the $0.30 SMA 20 level first, followed by sustained volume above the recent average. The Stochastic indicators (%K at 42.67, %D at 36.43) support this view as they remain below oversold territory with room for upward momentum.

Bearish Risk for Stellar
The bearish Stellar forecast centers on a failure to hold the $0.27 lower Bollinger Band support. A decisive break below this level targets the $0.25 immediate support, representing 14% downside risk from current prices.

Extended bearish pressure could drive XLM toward the $0.22 52-week low, particularly if broader cryptocurrency market conditions deteriorate. The negative MACD reading of -0.0163 confirms this risk remains present until momentum indicators show clear reversal signals.

November's historical weakness for Stellar adds credence to the bearish scenario, especially if the $0.2800 level fails to provide the expected technical bounce.

Should You Buy XLM Now? Entry Strategy
Based on current Stellar technical analysis, a staged entry approach offers the best risk-adjusted opportunity. The primary buy zone lies between $0.27-$0.28, allowing investors to capture potential bounces from the historical demand area identified by analysts.

For aggressive traders, the current $0.29 level presents a reasonable entry with a tight stop-loss at $0.26, just below the immediate support at $0.25. This setup offers a favorable 2:1 risk-reward ratio targeting the $0.32 short-term objective.

Conservative investors should wait for confirmation above $0.30 before establishing positions, as this would indicate successful reclaim of the SMA 20 and validate the bullish recovery thesis. Position sizing should remain modest given the mixed analyst sentiment and broader market uncertainties affecting the buy or sell XLM decision.

XLM Price Prediction Conclusion
The XLM price prediction for November 2025 suggests a cautiously optimistic outlook with $0.32 as the primary target over the next 7-10 days. This forecast carries medium confidence based on the confluence of oversold technical conditions, strong fundamental developments in smart contracts, and historical support levels.

Key indicators to monitor for confirmation include RSI breaking above 45, MACD histogram turning positive, and sustained daily closes above $0.30. Invalidation signals would include a break below $0.26 with heavy volume, which would shift the Stellar forecast toward the bearish $0.22-$0.25 range.

The timeline for this prediction spans the next 2-4 weeks, with the first major test coming at the $0.30-$0.32 resistance zone. Given the mixed analyst consensus and November's historically challenging performance for XLM, maintaining flexible position sizing and clear risk management remains essential for navigating this prediction period successfully.

Image source: Shutterstock

xlm price analysis
xlm price prediction

Chris Larsen celebrates Yellow Network's integration with XRPL's EVM sidechain, deepening Ripple-linked blockchain partnerships.

Zach Anderson
Nov 08, 2025 08:01

NEAR Protocol shows bullish momentum with analysts targeting $3.20-$3.50. Current technical setup suggests 20% upside potential as MACD turns positive.

NEAR Protocol has emerged as one of the standout performers in recent trading sessions, posting a remarkable 19.22% gain in the past 24 hours. With the token currently trading at $2.67, technical indicators are aligning to suggest further upside potential, making this NEAR price prediction particularly compelling for traders seeking the next breakout opportunity.

NEAR Price Prediction Summary
• NEAR short-term target (1 week): $2.90-$3.00 (+8-12%)
• NEAR Protocol medium-term forecast (1 month): $3.20-$3.50 range
• Key level to break for bullish continuation: $2.97 (immediate resistance)
• Critical support if bearish: $2.20 (SMA 20 confluence)

Recent NEAR Protocol Price Predictions from Analysts
The analyst community has shown remarkable alignment in their NEAR Protocol forecast, with multiple sources converging on similar upside targets. Blockchain.News leads the charge with a $3.20 medium-term price target, citing bullish momentum indicated by the MACD histogram at 0.0455 and RSI positioning at 59.84. This NEAR price prediction aligns closely with Coin Surges' $3.50 short-term target, contingent on increased demand driving a rally toward key resistance levels.

InvestingHaven takes a longer-term view with their ambitious $24 price target by 2030, though this represents a significant premium requiring sustained adoption and technological advancement. On the more conservative end, Bitget's model suggests a modest rise to $1.81 based on daily growth patterns, while AInvest News presents the lone bearish voice with potential decline toward $1.83-$1.84.

The consensus clearly favors upside, with four out of five recent predictions targeting higher prices, creating a foundation for our bullish NEAR price prediction framework.

NEAR Technical Analysis: Setting Up for Breakout
The current NEAR Protocol technical analysis reveals a compelling setup for continued upside momentum. The MACD histogram has turned positive at 0.0715, indicating bullish momentum is building beneath the surface. This represents a significant shift from recent bearish divergences and suggests the selling pressure that dominated earlier sessions is finally exhausting.

NEAR's positioning relative to the Bollinger Bands at 1.0227 shows the token is testing the upper band resistance at $2.65, but hasn't yet broken into overbought territory that would typically signal an immediate reversal. The RSI at 60.31 sits comfortably in neutral territory, providing ample room for further advancement before reaching overbought conditions above 70.

Volume analysis supports this bullish thesis, with 24-hour trading volume reaching $307.4 million on Binance spot markets alone. This represents significant institutional and retail interest, providing the fuel necessary for sustained price appreciation.

NEAR Protocol Price Targets: Bull and Bear Scenarios
Bullish Case for NEAR
The primary NEAR price target sits at $3.20, representing a 20% gain from current levels and aligning with analyst consensus. This target becomes achievable once NEAR clears the immediate resistance at $2.97, which represents the 24-hour high and a crucial technical barrier.

A secondary upside target emerges at $3.50, matching Coin Surges' prediction and representing a 31% gain. This level coincides with the 52-week high area and would require sustained momentum beyond initial resistance breaks.

For this bullish NEAR Protocol forecast to materialize, we need to see continued volume expansion above current levels, RSI maintaining its upward trajectory without entering extreme overbought territory, and most importantly, a decisive break above $2.97 with strong follow-through.

Bearish Risk for NEAR Protocol
Should the current rally fail to sustain momentum, our NEAR price prediction identifies key downside risks. The immediate support zone sits at $2.20, where both the SMA 7 and SMA 20 converge, creating a significant technical floor.

A break below this level would target the stronger support at $1.72, representing the lower range of recent trading activity. In an extreme bearish scenario, NEAR could retreat toward $1.55, which represents strong support from prior accumulation zones.

Risk factors to monitor include a potential RSI reversal from current levels, MACD histogram turning negative again, and most critically, a failure to break above $2.97 resistance with conviction.

Should You Buy NEAR Now? Entry Strategy
Based on our NEAR Protocol technical analysis, the optimal entry strategy involves a tiered approach. Conservative buyers should wait for a pullback to the $2.40-$2.45 range, which offers better risk-reward ratios while still maintaining exposure to the bullish thesis.

Aggressive traders can consider entries at current levels around $2.67, but should implement tight risk management with stop-losses below $2.20. This provides approximately 18% downside protection while maintaining upside exposure to our $3.20 price target.

Position sizing should remain conservative given the inherent volatility in cryptocurrency markets, with risk per trade not exceeding 2-3% of total portfolio value. The decision to buy or sell NEAR ultimately depends on individual risk tolerance and technical conviction in the breakout scenario.

NEAR Price Prediction Conclusion
Our comprehensive NEAR price prediction points toward continued upside momentum, with a high-confidence target of $3.20 within the next four weeks. This forecast carries medium-to-high confidence based on converging technical indicators, analyst consensus, and strong volume support.

Key indicators to watch for confirmation include maintaining the $2.20 support level, RSI holding above 55, and most importantly, a decisive break above $2.97 resistance. Invalidation signals would include a break below $2.20 or RSI falling below 45, which would necessitate a reassessment of the bullish thesis.

The timeline for this NEAR Protocol forecast extends through December 2025, with intermediate checkpoints at the $2.90-$3.00 range expected within 7-10 trading days. Given the current technical setup and analyst alignment, this represents one of the more compelling cryptocurrency predictions in the current market environment.

Image source: Shutterstock

near price analysis
near price prediction